Picture Berlin Partner Bionnale 2021 Digital Event 650x80px
Organisation › Details

Sandoz (division of Novartis)

Sandoz is a global leader in generic pharmaceuticals and biosimilars. As a division of the Novartis Group, our purpose is to discover new ways to improve and extend people's lives. We contribute to society's ability to support growing healthcare needs by pioneering novel approaches to help people around the world access high-quality medicine. Our portfolio of approximately 1,000 molecules, covering all major therapeutic areas, accounted for 2017 sales of USD 10.1 billion. In 2017, our products reached well over 500 million patients. Sandoz is headquartered in Holzkirchen, in Germany's Greater Munich area. *


Period Start 2003-05-01 renamed
  Group Novartis (Group)
Product Industry pharmaceutical
Person Person Saynor, Richard (Novartis 2019Q1– CEO of Sandoz)
Region Region Holzkirchen
  Country Germany
  Street 25 Industriestr.
  City 83607 Holzkirchen
  Tel +49-8024-476-0
    Address record changed: 2020-12-02
Basic data Employees H: 10,001 to 50,00 (2005-05-27)
  Currency USD
  Annual sales 3,000,000,000 (sales (annual) 2004-01-01)
    * Document for �About Section�: Novartis AG. (7/27/18). "Press Release: Sandoz Receives European Commission Approval for Biosimilar Hyrimoz (adalimumab)". Holzkirchen.
Record changed: 2021-02-11


Picture EBD Group Global Partnering Four Events One Price 650x80

More documents for Novartis (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture EBD Group ChinaBio Partnerting Forum 2021 651x80

» top